Precision AQ - Investor Relations & External Communications’ Post

With late-stage data in Alzheimer’s disease due in the coming months, Athira Pharma’s CEO, Mark Litton,Ph.D., sat down with Hannah Deresiewicz, EVP of Precision AQ, while at the Jefferies Global Healthcare Conference to discuss his excitement for the future and the Company’s novel approach to battling a variety of neurodegenerative diseases.

To view or add a comment, sign in

Explore topics